Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.65% |
| Dec 31, 2025 | -7.44% |
| Sep 30, 2025 | -18.00% |
| Jun 30, 2025 | -14.81% |
| Mar 31, 2025 | -4.13% |
| Dec 31, 2024 | 25.07% |
| Sep 30, 2024 | -6.18% |
| Jun 30, 2024 | -17.61% |
| Mar 31, 2024 | -9.73% |
| Dec 31, 2023 | -11.69% |
| Sep 30, 2023 | 5.97% |
| Jun 30, 2023 | 17.51% |
| Mar 31, 2023 | 1.80% |
| Dec 31, 2022 | -9.10% |
| Sep 30, 2022 | -7.70% |
| Jun 30, 2022 | 4.97% |
| Mar 31, 2022 | 16.37% |
| Dec 31, 2021 | 36.88% |
| Sep 30, 2021 | 28.11% |
| Jun 30, 2021 | -28.60% |
| Mar 31, 2021 | 6.47% |
| Dec 31, 2020 | 3.57% |
| Sep 30, 2020 | 32.02% |
| Jun 30, 2020 | 38.15% |
| Mar 31, 2020 | 23.62% |
| Dec 31, 2019 | -4.19% |
| Sep 30, 2019 | 10.78% |
| Jun 30, 2019 | 29.00% |
| Mar 31, 2019 | 42.41% |
| Dec 31, 2018 | 75.82% |
| Sep 30, 2018 | 48.47% |
| Jun 30, 2018 | 17.61% |
| Mar 31, 2018 | -2.11% |
| Dec 31, 2017 | 26.83% |
| Sep 30, 2017 | 44.26% |
| Jun 30, 2017 | 41.24% |
| Mar 31, 2017 | -1.48% |